학술논문
Baricitinib treatment of severe chronic hand eczema: Two case reports.
Document Type
Article
Source
Subject
*ECZEMA
*BARICITINIB
*JAK-STAT pathway
*
*
Language
ISSN
0105-1873
Abstract
Keywords: baricitinib; hand dermatitis; hand eczema; hyperkeratotic hand eczema; atopic hand eczema; JAK-inhibitor; treatment EN baricitinib hand dermatitis hand eczema hyperkeratotic hand eczema atopic hand eczema JAK-inhibitor treatment 419 421 3 04/14/22 20220501 NES 220501 Janus Kinase (JAK) inhibitors target the JAK and signal transducer and activator of transcription (STAT) signaling pathway that modulates T helper (Th)1, Th2, Th17, and Th22 signaling and is involved in many immune-mediated diseases. Hand dermatitis, hand eczema, treatment, baricitinib, hyperkeratotic hand eczema, atopic hand eczema, JAK-inhibitor. [Extracted from the article]